15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | RA Capital Management Peter Kolchinsky | 39,646,039 | $44,007,103 | +75% | 0.58% |
2. | Lynx1 Capital Management Weston Nichols | 637,218 | $707,312 | 0.26% | |
3. | Sarissa Capital Management Alex Denner | 618,000 | $685,980 | 0.21% | |
4. | Renaissance Technologies Jim Simons | 529,500 | $587,745 | -30% | 0% |
5. | Millennium Management Israel Englander | 261,837 | $290,639 | -14% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.00 | 38,974,101 | 38,974,101 | 2024-12-30 | Filing | ||
$18.00 | 130,970 | Large Shareholder, Director | 1,825,326 | 2021-02-09 | Filing | |
$18.00 | 2,848,596 | Large Shareholder, Director | 8,297,265 | 2021-02-09 | Filing | |
$18.00 | 444,444 | Large Shareholder | 1,858,470 | 2021-02-09 | Filing | |
$18.00 | 111,111 | Large Shareholder | 4,833,959 | 2021-02-09 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.42 | 2,227 | 126,625 | 2025-02-13 | Filing | ||
$1.37 | 2,554 | 128,852 | 2025-02-10 | Filing | ||
$1.25 | 10,334 | 81,439 | 2024-12-27 | Filing | ||
$1.39 | 14,645 | 96,063 | 2024-06-03 | Filing | ||
$15.30 | 91,836 | Large Shareholder | 1,766,634 | 2021-11-16 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 6,419,633 | $7,125,792 | 0% | |
2. | 6,361,723 | $7,061,513 | 1.68% | |
3. | 1,942,821 | $2,156,531 | 0% | |
4. | 1,074,658 | $1,192,870 | 0.3% | |
5. | 488,363 | $542,083 | 0% |